{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-216388","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2021-07-15T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.709608+00:00","generated_at":"2026-06-30T05:07:33.493973+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Viridian appoints Jennifer Moses, CPA to board and as Audit Committee Chair","bullets":["Appointed Jennifer Moses as Class II director and Chair of Audit Committee, effective July 14, 2021.","Moses serves as CFO of G1 Therapeutics (GTHX) since 2019; previously partner at Rankin McKenzie.","Receives $55k annual cash retainer; granted option for 25,000 shares at July 14 closing price, vesting over 3 years.","CPA with B.S. in Accounting from Penn State; held roles at Deloitte including strategic planning."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-216388","json":"https://secwatch.observer/filing/0001193125-21-216388.json","markdown":"https://secwatch.observer/filing/0001193125-21-216388.md","text":"https://secwatch.observer/filing/0001193125-21-216388.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/0001193125-21-216388-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/d200433d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T05:07:33.493973+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9e82f61947","claim":"Jennifer K. Moses was appointed as Director at Viridian Therapeutics, Inc.\\DE.","evidence_excerpt":"On July 14, 2021, the board of directors (the “Board”) of Viridian Therapeutics, Inc. (the “Company”) appointed Jennifer K. Moses as a member of the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1590750/000119312521216388/0001193125-21-216388-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}